With a market cap of $17.1 billion, Zimmer Biomet Holdings, Inc. (ZBH) is a leading global medical technology company that specializes in orthopedic implants, surgical products, and digital solutions designed to improve mobility and musculoskeletal health. Headquartered in Warsaw, Indiana, the company traces its roots back to 1927 and operates in more than 100 countries.
Companies worth $10 billion or more are generally described as “large-cap stocks,” and Zimmer Biomet fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical devices industry. Its competitive advantages stem from its strong position as one of the world's largest orthopedic device manufacturers, supported by a broad portfolio of hip, knee, shoulder, and trauma implants, as well as advanced surgical technologies. The company benefits from well-established relationships with hospitals and surgeons, a globally recognized brand, and significant scale that supports research, innovation, and distribution.